Atossa Genetics (ATOS) Reports Q1 Loss of $0.13/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Atossa Genetics (ATOS) Reports Q1 Loss of $0.13/Share

Atossa Genetics Announces First Quarter 2015 Financial Results and Provides Company Update

May 13, 2015 4:01 PM EDT

SEATTLE, WA -- (Marketwired) -- 05/13/15 -- Atossa Genetics Inc. (NASDAQ: ATOS) today announced first quarter 2015 financial results and provided an update on recent company developments.

Steve Quay, President and CEO, commented, "We have made tremendous progress towards achieving our 2015 objectives by launching the ForeCYTE Breast Aspirator in the European Union and the FullCYTE Breast Aspirator in the United States. We engaged key national distributors in the United States and are seeing very strong growth with our pharmacogenomics tests. We look forward to continued progress towards our other key 2015 objectives, which are to... More